Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes. They developed the RaniPill capsule, which is Rani's novel, proprietary, and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The RaniPill capsule is an orally ingestible pill approximately the size of a “000” capsule (or similar to the size of a standard fish oil or calcium pill) that is designed to automatically administer a precise therapeutic dose of medication upon deployment in the small intestine. To date, Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability, and bioavailability using the RaniPill capsule. Their development efforts have enabled them to construct an extensive intellectual property portfolio that they believe provides patients with a competitive advantage.

IntraPace® has developed a novel implantable system to treat obesity. It is built on the proven technology used in millions of cardiac pacemakers and defibrillators each year. The abiliti® system is designed to be implanted via standard laparoscopic instruments without making any changes to the anatomy of the digestive system or placing any limitations on what a person can eat or drink.

Digma Medical is a clinical stage medical device company revolutionizing the treatment of Type-2 Diabetes and other metabolic syndrome disease such as NASH. Founded in 2013 and backed by leading venture capital firms, Digma is dedicated to the development of the DiaGone™ to treat insulin resistance - the underlying mechanism of the disease. The DiaGone™ is an endoscopic, disposable device, that uses state of the art laser technology to treat the duodenum without an implant. The Duodenal Glycemic Control™ procedure is a one-time 30 minute GI procedure, in which the gastroenterologist uses the DiaGone™ to treat the duodenum for restoring the natural ability of the body to control glucose levels, which may provide long term remission from Type-2 Diabetes, NASH, and other metabolic syndrome related disease.

Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA.

Biovail Laboratories, Inc., a subsidiary of Bausch Health Cos., Inc., is a Canadian company. The firm provides clinical testing and drug development services.

Academisch Ziekenhuis Maastricht operates as medical research centre. The company is headquartered in Maastricht, the Netherlands.

InCube Labs is a life sciences research lab focused on developing medical breakthroughs that dramatically improve patient outcomes. Their multi-disciplinary approach integrates traditional device technologies such as electronics, software, mechanical engineering and material science, with innovations from the pharmaceutical industry, often involving protein chemistry, pharmacology and cell biology. InCube is led by Mir Imran, an accomplished medical innovator, entrepreneur and venture capitalist, who has founded more than 20 life sciences companies and holds more than 200 patents. Many of Imran’s innovations have resulted in new standards of care, including the first FDA-approved Automatic Implantable Cardioverter Defibrillator.

E-Pill Pharma Ltd. develops oral drug delivery platform. Its drug delivery platform is used to administer peptides, molecule and low bioavailability drugs, such as insulin, growth hormone, LMW Heparin, PTH, and interferon. The company was founded in 2003 by Yossi Gross and Yoram Sela and is headquartered in Caesarea, Israel.

Guangzhou Consun Pharmaceutical Co., Ltd. engages in the research, production, and sale of pharmaceutical and healthcare products. Its products include granules, tables, small volume and large capacity injection, pharmaceutical raw materials, oral solutions, Chinese medicine processing, and oral formulation. The company was founded on December 29, 1997 and is headquartered in Guangzhou, China.

Guangzhou Baodan Medical Equipment Technology Co., Ltd., established on 2008-10-23, The scope of business includes the manufacture of optical instruments;computer,Retailing of Software and Ancillary Equipment;Import and export(Excluding franchised products);Medical Research and Experimental Development;Technology Import and Export;Medical Equipment Repair;medical diagnosis,Monitoring and treatment equipment manufacturing;Manufacturing of medical disinfection equipment and appliances;Manufacture of Mechanical Therapy and Ward Nursing Equipment;two,Wholesale of Class III Medical Devices;medical diagnosis,Monitoring and treatment equipment retail;surgery,Dental and other medical special equipment and equipment manufacturing;Manufacturing of medical laboratory equipment and appliances;medical diagnosis,Monitoring and treatment equipment wholesale;

Hunan Huize Biomedical Technology Co., Ltd., established on 2014-09-25, Business scope includes biomedicine,Research and development of health food,consult,Technology transfer and provision of related technical services in the production process;Preclinical pharmacokinetic research and development,technical consulting,technology transfer;account Serive;Chemical reagents for new drug development,Chemical raw materials(Free of hazardous and monitored chemicals),Sales of electronic instruments.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Part of Medtronic Plc, Covidien Pte Ltd. is a Singaporean company located in Singapore that manufactures and supplies medical equipment.

Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

Freedom Health LLC is an American private company located in Aurora, OH, that produces digestive aids for horses and engages in research and development of products for human gastrointestinal health.

Biovail Laboratories International SRL, a subsidiary of Bausch Health Cos., Inc., is a company headquartered in Saint Michael, Barbados, that develops, manufactures, and sells pharmaceutical products.

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).